Pacific Equity Partners (PEP) has sweetened its takeover offer for Spotless Group (SPT.AX), bringing the deal value above the A$743 million ($765 million) that the Australian business services company has been seeking, two sources with knowledge of the deal told Reuters.
Sectors
India's Intas to raise 3 bln rupees from ChrysCap
Indian drugmaker Intas Pharmaceuticals said it was raising 3 billion rupees ($57 million) from private equity firm ChrysCapital ahead of its initial public offering.
miRagen Therapeutics Secures $20 Million Series B Financing
The Series B financing provides further validation of miRagen and the promise of microRNA-based therapeutics.
Terascala Announces $14M Series B Funding Round Led by Strategic Partner Consortium
Terascala is a leader in the development of solutions that address this requirement, and the fact that its product runs on an open source file system and on industry-standard platforms makes for a very compelling value proposition in a price sensitive market.
MaRS announces JOLT: New technology accelerator will combine creative design and business expertise to build growth companies
MaRS today announced the creation of JOLT, a new technology accelerator dedicated to building high-growth web and mobile companies that promise to transform the way consumers and enterprises connect, work and play.
Latest News
Private equity firm CVC Capital Partners Ltd will buy a majority stake in AlixPartners LLP as the restructuring and consulting firm looks to develop its services and expand geographically.
Sumitomo Mitsui Financial Group will buy a 24 percent stake in a mid-sized Chinese asset management firm for around $125 million, two sources with direct knowledge of the matter said, a move that would be its first foray in China's wealth management market.
China's rigid capital rules ban its citizens from investing directly in Apple Inc but that's not keeping them from seeking a piece of the iPhone maker's success by buying shares in its suppliers - and even companies rumored to be suppliers.
The purpose is to complete the product development and market introduction of Accelr8’s BACcel™ culture-free, diagnostic system for same-shift identification and antibiotic resistance testing of bacterial and fungal pathogens.
This increase in funding limit allows CRS to take advantage of opportunities in the market place for both organic and external growth
Impact Investment Fund Partners with Express Life to reach 500,000 in Ghana with Financial Services
Company Enters Strategic Growth Phase, Rooted in the Strength of Its IT Operations and Cloud Management Platform for Service Providers and Corporations.
U.S. Bank and Jay Paul Company announced today they have closed on a $284.7 million construction/bridge loan that will finance Moffett Towers Phase II, a 1,033,000 square-foot, Class A mid-rise office project in Sunnyvale, Calif.
Financing Supports Clinical Development of ALD403, Unpartnered Program for the Treatment of Migraine, and of ALD518 in Cancer-related Indications.
